SciELO - Scientific Electronic Library Online

 
vol.20 issue5Controversies in current management of the aortic coarctation author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Cardiología

Print version ISSN 0120-5633

Abstract

LOPEZ-JARAMILLO, Patricio et al. Incretin analogs and inhibitors of DPP-4: which is their role in the primary prevention of cardiovascular diseases?. Rev. Colomb. Cardiol. [online]. 2013, vol.20, n.5, pp.287-299. ISSN 0120-5633.

Type 2 diabetes mellitus (T2DM) is a highly prevalent disease, which has shown a rapid increase in recent decades, doubling the number of people with this disease. Several epidemiological studies show that 70% of diabetes deaths are caused by cardiovascular events (coronary heart disease and stroke). Recently there has been an expansion in the discovery of drugs for the management of type 2 diabetes. These drugs must demonstrate additional cardiovascular system benefits before its introduction in the market. This paper aims to determine the role of new antidiabetic drugs that act on the incretin system and its effects on the primary prevention of cardiovascular events.

Keywords : diabetes; cardiovascular disease; pharmacology; inhibitors.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )